Cargando…
HN1L/AP-2γ/PLK1 signaling drives tumor progression and chemotherapy resistance in esophageal squamous cell carcinoma
Hematological and neurological expressed 1 like (HN1L) is a newly identified oncogene in lung cancer and hepatocellular carcinoma recently identified by our team, but its roles in the development and treatment of esophageal squamous cell carcinoma (ESCC) remain incompletely cataloged. Here, using ES...
Autores principales: | Zeng, Ting-Ting, Deng, Tian-Hao, Liu, Zhen, Zhan, Jia-Rong, Ma, Yuan-Zhen, Yan, Yuan-Yuan, Sun, Xiao, Zhu, Ying-Hui, Li, Yan, Guan, Xin-Yuan, Li, Lei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9729194/ https://www.ncbi.nlm.nih.gov/pubmed/36476988 http://dx.doi.org/10.1038/s41419-022-05478-1 |
Ejemplares similares
-
Plumbagin inhibits the proliferation and survival of esophageal cancer cells by blocking STAT3-PLK1-AKT signaling
por: Cao, Ying-Ya, et al.
Publicado: (2018) -
Chaetoglobosin E inhibits tumor growth and promotes the anti-tumor efficacy of cytotoxic drugs in esophageal squamous cell carcinoma by targeting PLK1
por: Chen, Jin-Hua, et al.
Publicado: (2022) -
Risk factors for lymph node metastasis in T1 esophageal squamous cell carcinoma: A systematic review and meta-analysis
por: Jiang, Kai-Yuan, et al.
Publicado: (2021) -
ADAM9 functions as a transcriptional regulator to drive angiogenesis in esophageal squamous cell carcinoma
por: Lin, Yu-Sen, et al.
Publicado: (2021) -
Peritumoral B cells drive proangiogenic responses in HMGB1-enriched esophageal squamous cell carcinoma
por: Kam, Ngar Woon, et al.
Publicado: (2021)